Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: A single-arm phase II study

Author(s):
Vermeij, R.; Leffers, N.; Hoogeboom, B.N.; Hamming, I.L.E.; Wolf, R.; Reyners, A.K.L.; Molmans, B.H.W.; Hollema, H.; Bart, J.; Drijfhout, J.W. (0000-0003-4808-5296); Oostendorp, J.; Zee, A.G.J. van der; Melief, C.J.; Burg, S.H. van der (0000-0002-6556-0354); Daemen, T.; Nijman, H.W.
Published
2012
Publication type
Article / Letter to editor
immunotherapyovarian cancerp53vaccinecyclophosphamide
Date issued
2012-09-01
Language
English
Is part of
hdl
1887/118396
doi
10.1002/ijc.27388